Publicacions en què col·labora amb Juan José Vaquero López (11)

2023

  1. Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure

    Nutrients, Vol. 15, Núm. 8

2022

  1. Insight into the mechanism of molecular recognition between human Integrin-Linked Kinase and Cpd22 and its implication at atomic level

    Journal of Computer-Aided Molecular Design, Vol. 36, Núm. 8, pp. 575-589

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core

    ChemMedChem, Vol. 16, Núm. 18, pp. 2895-2906

  2. Pyrrolo[1,2-a]quinoxal-5-inium salts and 4,5-dihydropyrrolo[1,2-a]quinoxalines: Synthesis, activity and computational docking for protein tyrosine phosphatase 1B

    Bioorganic and Medicinal Chemistry, Vol. 44

  3. Tripeptides as Integrin-Linked Kinase Modulating Agents Based on a Protein-Protein Interaction with α-Parvin

    ACS Medicinal Chemistry Letters, Vol. 12, Núm. 11, pp. 1656-1662

2020

  1. Pyrrolo[1,2-a]quinoxalines: Insulin Mimetics that Exhibit Potent and Selective Inhibition against Protein Tyrosine Phosphatase 1B

    ChemMedChem, Vol. 15, Núm. 19, pp. 1788-1801

  2. The pHLIP system as a vehicle for microRNAs in the kidney

    Nefrologia, Vol. 40, Núm. 5, pp. 491-498

2018

  1. Discovery of potent calpain inhibitors based on the azolo-imidazolidenone scaffold

    European Journal of Medicinal Chemistry, Vol. 157, pp. 946-959

2012

  1. New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers

    European Journal of Medicinal Chemistry, Vol. 50, pp. 90-101

2009

  1. Losartan-antioxidant hybrids: Novel molecules for the prevention of hypertension-induced cardiovascular damage

    Journal of Medicinal Chemistry, Vol. 52, Núm. 22, pp. 7220-7227